fbpx

ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

Can psychedelics lift the fog of depression?
5. September 2019
Studying microscopic motors in the stomach
26. August 2019
Parkinson-symptomer invaderede fra tarmsystemet
Parkinson’s symptoms invade from the gut
18. July 2019